# FDA Warning Letter: Sagent Pharmaceuticals, Inc.
> 2022-12-20 · Division Pharmaceutical Quality Operations I · `948ecdc3dfd3754a`
## Letter
- **Company:** Sagent Pharmaceuticals, Inc.
- **Posted Date:** 2022-12-20
- **Letter Issue Date:** 2022-07-27
- **Issuing Office:** Division Pharmaceutical Quality Operations I
## Subject
CGMP/Drugs/Adulterated
---
*Source: [FDA Warning Letters](https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters) · AI Analytics · CC0 1.0*